NCT02300311 - Efficacy and Safety of Finalgon® Cream Multiple Doses in Acute Low Back Pain | Biotech Hunter

Enrollment

138

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Low Back Pain

Interventions

DRUG

nonivamide + nicoboxil (Finalgon cream)

2 cm cream line for a skin area approximately 20 x 20 cm2 up to 3 times in a 24 hour period

DRUG

placebo matching nonivamide + nicoboxil (Finalgon cream)

2 cm cream line for a skin area of approximately 20 x 20 cm2 up to 3 times in a 24h period

Trial Locations (8)

69.53.53201 Boehringer Ingelheim Investigational Site, Kyiv

69.53.53102 Boehringer Ingelheim Investigational Site, Saint Petersburg

69.53.53103 Boehringer Ingelheim Investigational Site, Saint Petersburg

69.53.53105 Boehringer Ingelheim Investigational Site, Saint Petersburg

69.53.53106 Boehringer Ingelheim Investigational Site, Saint Petersburg

69.53.53107 Boehringer Ingelheim Investigational Site, Saint Petersburg

69.53.53202 Boehringer Ingelheim Investigational Site, Kyiv

69.53.53203 Boehringer Ingelheim Investigational Site, Kyiv